Ideas

October 17, 2017

Published by admin_auro at October 17, 2017

Categories

Natural product therapy for Glaucoma: Isorhapontigenin, isolated from Genetum and Norway spruce (Picea abies), and sitka spruce (Picea sitchensis), among others, increases Nmnat1 expression, increases NAD+ levels, improves neuroanl dysfunction, and protects against glaucoma via down regulation of its target gene, 17/October/2017, 11.34 pm

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, […]

October 17, 2017

Published by admin_auro at October 17, 2017

Categories

Ideas
Stroke

Natural product-derived therapy for Stroke: Glabridin, isolated from Licorice/Glycyrrhiza glabra L, which is used as a food additive (Sweetener), attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 17/October/2017, 11. 23 pm

Introduction: What they say A recent study from Research Center for Neurobiology and Department of Neurobiology, Xuzhou Medical College, 209 Tongshan Road, Xuzhou, Jiangsu 221004, PR China; […]

October 17, 2017

Published by admin_auro at October 17, 2017

Categories

Life-extension therapy: Triptolide, isolated from Thunder God Vine, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 17/October/2017, 10.52 pm

What they say: A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal […]

October 16, 2017

Published by admin_auro at October 16, 2017

Categories

Ideas
NAFLD

Xenon-based therapy for Non-alcoholic fatty liver disease (NAFLD): Xenon promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 17/October/2017, 12.58 am

Significance of the study: Given that: (1) 15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while 6-25% of Asian populations suffer from it; (2) 75 to […]